Abstract
Previous study showed that aerosolized signal transducer and activator of transcription-1 (STAT1) antisense oligodeoxynucleotide (ASON) inhibited the expression of STAT1 and ICAM-1 mRNA and protein in alveolar macrophages (AMs) and decreased the concentrations of TGF-β, PDGF and TNF-α in bronchioalveolar lavage fluid (BALF) in bleomycin (BLM)-induced rat pulmonary fibrosis. Administration of STAT1 ASON ameliorated alveolitis in rat pulmonary fibrosis. However, further investigations are needed to determine whether there is an effect from administration of STAT1 ASON on fibrosis. This study investigated the effect of aerosolized STAT1 ASON on the expressions of inflammatory mediators, hydroxyproline and type I and type III collagen mRNA in BLM-induced rat pulmonary fibrosis. The results showed that STAT1 ASON applied by aerosolization could ameliorate alveolitis and fibrosis, inhibit the expressions of inflammatory mediators, decrease the content of hydroxyproline, and suppress the expressions of type I and type III collagen mRNA in lung tissue in BLM-induced rat pulmonary fibrosis. These results suggest that aerosolized STAT1 ASON might be considered as a promising new strategy in the treatment of pulmonary fibrosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, W., Liao, B., Zeng, M. et al. The Effects of Aerosolized STAT1 Antisense Oligodeoxynucleotides on Rat Pulmonary Fibrosis. Cell Mol Immunol 6, 51–59 (2009). https://doi.org/10.1038/cmi.2009.7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2009.7
Keywords
This article is cited by
-
Pre-Differentiation of KIND1 Human Embryonic Stem Cell Line into Type I Alveolar Epithelial Cells Alleviates Symptoms of Idiopathic Pulmonary Fibrosis in Mice
Proceedings of the Zoological Society (2023)
-
Hyperoxia-Preconditioned Human ESC Line KIND1, Predominantly Differentiated into SP-C+ Type-II Alveolar Epithelial Cells, Reduces Idiopathic Pulmonary Fibrosis in Mice
Proceedings of the Zoological Society (2023)
-
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis
Fibrogenesis & Tissue Repair (2010)